The global Pen Needles Market is anticipated to reach $12.88 billion by 2031, growing at a compound annual growth rate (CAGR) of 9.9%, according to a recent report by Meticulous Research®. The market's growth is primarily driven by the rising prevalence of diabetes, increased demand for self-administered drugs, technological advancements, and higher healthcare expenditures. Additionally, the preference for pen needles over traditional vials and syringes, favorable reimbursement policies, and growth opportunities in emerging economies are key factors contributing to market expansion.
Market Drivers and Challenges
The market’s growth is propelled by various factors, including:
Rising Diabetes Prevalence: As the global diabetic population increases, so does the demand for effective insulin delivery methods, including pen needles.
Technological Advancements: Innovations in pen needle design and functionality are improving patient experiences and safety.
Self-administration Trend: A growing number of patients prefer the convenience and control offered by pen needles for self-administering medications.
Download Sample Copy: https://www.meticulousresearch.com/download-sample-report/cp_id=5796
However, the market faces several challenges, such as:
Needlestick Injury Concerns: The risk of injuries remains a significant barrier to adoption.
Reuse of Pen Needles: The improper reuse of pen needles, particularly in developing regions, poses a risk to patient safety.
Healthcare Access and Awareness: Limited access to healthcare and a lack of awareness regarding proper needle usage hinder market growth, especially in low-income regions.
Market Segmentation
The pen needles market is segmented by:
Type: Standard Pen Needles, Safety Pen Needles
Needle Length: 4 mm, 5 mm, 6 mm, 8 mm, 10 mm, 12 mm Above
Usability: Single-use/Disposable, Reusable
Application: Insulin Therapy, Growth Hormone Therapy, GLP-1 Therapy, Other Applications
Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Healthcare Setting: Home Care, Hospitals Clinics, Other Healthcare Settings
Key Segment Highlights
Safety Pen Needles: Expected to dominate the market by 2024 due to their ability to reduce needlestick injuries and ensure safe medication delivery. The addition of safety features like shields further enhances their appeal.
4 mm Needle Length: The 4 mm segment is projected to hold the largest market share by 2024, driven by its minimal discomfort during injections. Companies are focusing on innovative products in this segment, such as Terumo Group's FineGlide.
Single-use/Disposable Pen Needles: Set to lead the market in 2024, propelled by advancements in insulin delivery devices and growing awareness of hygiene and safety.
Insulin Therapy Application: Expected to dominate the application segment by 2024, fueled by the increasing demand for insulin therapy due to the high prevalence of diabetes. The global diabetic population is expected to grow from 537 million in 2021 to 783 million by 2045.
Retail Pharmacies: This distribution channel is expected to be the largest by 2024, offering convenience and accessibility for patients managing diabetes.
Home Care Setting: Projected to hold the largest share in 2024 as more patients manage their healthcare independently, integrating treatment into daily routines and improving medication adherence.
Get Customized Report: https://www.meticulousresearch.com/request-customization/cp_id=5796
Regional Insights
The pen needles market is analyzed across major geographies, including North America, Europe, Asia-Pacific, Latin America, and the Middle East Africa. In 2023, North America is anticipated to lead the market, supported by a well-established healthcare infrastructure and the presence of key industry players such as Becton, Dickinson and Company (U.S.) and Cardinal Health, Inc. (U.S.).
Key Players in the Market
The market is highly competitive, with major players including: Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Owen Mumford Limited (U.K.), B. Braun Melsungen AG (Germany), Terumo Group (Japan), Allison Medical, Inc. (U.S.), Cardinal Health, Inc. (U.S.), UltiMed, Inc. (U.S.), Hindustan Syringes Medical Devices Ltd (India), and Nanchang YiLi Medical Instrument Co.,LTD (China).
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
